| Descriptions | Industry | Location | Stage | Financial status | Funding needed |
|---|---|---|---|---|---|
| Breakthrough Therapy for Auto-Immune Diseases; Multiple Indication Product: Completed Phase II Trial in T1D, ready to enter Phase III | BioTech | Cedar Knolls, NJ | Series A+ | Seed in progress | $60M |
| Global leading implantable medical solutions | BioTech | Fremont, CA | Series B | Closed series B | |
| Novel stem cell technology targeting unmet medical needs | BioTech | Fremont, CA | Seed | Pre-A in progress |
OKOsix
MetaY
Traini
Zeda Health
APStem
TetraMEM
Contact us to unlock more details
Contact us to unlock more details
Contact us to unlock more details
Contact us to unlock more details
Global leading implantable medical solutions
Zeda, Inc. Closes $52 Million Series B Financing Round
Learn MoreContact us to unlock more details
Contact us to unlock more details